3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Obesity, Morbid

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Obesity, Morbid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ackermans, MT; Berends, FJ; Booij, J; de Weijer, BA; Fliers, E; Janssen, I; la Fleur, SE; Serlie, MJ; van de Giessen, EM; van de Laar, A; van der Zwaal, EM	1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Obesity, Morbid

Article	Year
Striatal dopamine D2/3 receptor availability increases after long-term bariatric surgery-induced weight loss. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2016, Volume: 26, Issue:7 Topics: Adult; Benzamides; Blood Glucose; Body Mass Index; Corpus Striatum; Feeding Behavior; Female; Follow-Up Studies; Gastric Bypass; Ghrelin; Humans; Leptin; Obesity, Morbid; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Weight Loss	2016

Article

Year

Striatal dopamine D2/3 receptor availability increases after long-term bariatric surgery-induced weight loss.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2016, Volume: 26, Issue:7

Topics: Adult; Benzamides; Blood Glucose; Body Mass Index; Corpus Striatum; Feeding Behavior; Female; Follow-Up Studies; Gastric Bypass; Ghrelin; Humans; Leptin; Obesity, Morbid; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Weight Loss

2016